NCT04592809View on ClinicalTrials.gov

Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

June 1, 2026

Study Completion Date

December 1, 2026

Conditions
Suicide, AttemptedSuicide and DepressionSuicide Threat
Interventions
DRUG

Ketamine Hydrochloride

infused over a 40 minute period

DRUG

Midazolam Hydrochloride

infused over a 40 minute period

Trial Locations (1)

75235

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Texas Southwestern Medical Center

OTHER